ICTHIC

271 posts

ICTHIC

@ICTHIC

ICTHIC promotes recent advances in the understanding of the pathogenesis, prevention and treatment of thrombohemorrhagic complications in cancer patients

Bergamo, Lombardy Beigetreten Nisan 2019

263 Folgt446 Follower

ICTHIC retweetet

Dr Jean Pierre Laroche@Echoraljpangio·19 May

@MarcCarrier1 GREAT Marc

Faizan Khan, PhD@FaizanK91

Sad to have missed #ICTHIC2024 this year. Thanks @MarcCarrier1 for presenting our meta-analysis of prognostic factors associated w/ recurrent #VTE in patients with cancer-associated VTE. Stay tuned for the full publication, including factors for bleeding in these patients.

English

150

ICTHIC retweetet

Tzu-Fei Wang@TzufeiWang·19 May

A grant finale of #ICTHIC2024 🎆Systematic review and meta-analysis by Dr. @MarcCarrier1 et. al identified multiple risk factors for recurrent VTE in patients with cancer-associated thrombosis.

English

2.5K

ICTHIC retweetet

Marc Carrier@MarcCarrier1·19 May

Dr. @jzbos demonstrated that proteomics can help to predict cancer-associated thrombosis and provide innovative mechanistic insights (through CD200R1/IL-17A axis). Looking forward seeing additional results at the @isth meeting in Bangkok. @ICTHIC

English

2.1K

ICTHIC retweetet

Lucy NORRIS@LucyNORTCD·18 May

Great presentation by @SimonNoble at #icthic24 explaining the importance of involving patients at every stage of research. #PPI is sadly neglected in #cancer associated #thrombosis research. Would be great to see patient representatives at the next @icthic?

English

425

ICTHIC retweetet

Marc Carrier@MarcCarrier1·19 May

Is FXI inhibition the future of the management of cancer-associated thrombosis? Dr. @MarcelloDiNisio provided an elegant review @ICTHIC Potentially low risk of bleeding, less drug-drug interactions, less dependence on renal/liver for elimination. Phase 3 trials on-going! Stay tuned :)

English

4.2K

ICTHIC retweetet

Marc Carrier@MarcCarrier1·19 May

Dr. @aakonc highlighting that RCTs assessing Immune Checkpoint Inhibitors for patients with cancer do not capture a large majority of VTEs or ATEs (RCTs vs. Cohorts) @ICTHIC meeting👇 #ICTHIC2024

English

1.5K

ICTHIC retweetet

Tzu-Fei Wang@TzufeiWang·18 May

Dr. Stanworth gave an elegant talk on the challenges in managing patients with thrombocytopenia and cancer-associated thrombosis, RCT is underway and needed! #ICTHIC2024

English

834

ICTHIC retweetet

Alok Khorana, MD@aakonc·18 May

Closing up day#2 @ICTHIC #ICTHIC24 with the one and only @SimonNoble on pt/public involvement in CAT research

English

891

ICTHIC retweetet

Alok Khorana, MD@aakonc·18 May

Day 2 of @ICTHIC #ICTHIC24 kicks off with an important overview of #VTE and mortality in heme malignancies by @KSanfilippoMD

English

1.2K

ICTHIC retweetet

Marc Carrier@MarcCarrier1·17 May

Fantastic 8th Simon Karpatkin Memorial Lecture at @ICTHIC by Prof Agnes Lee. Interesting overview of the management of cancer-associated thrombosis highlighting an exceptional career by Prof Lee. 🏆 🎉

English

1.3K

ICTHIC retweetet

Alok Khorana, MD@aakonc·17 May

It's not just #VTE, @debsiegal describes the impact of stroke in people with cancer #ICTHIC24 @ICTHIC @icthicmagazine

English

1.1K

ICTHIC@ICTHIC·22 Nis

Online Registration Ending Soon! 12th ICTHIC Bergamo, Italy, May 17-19, 2024 REGISTER NOW: icthic.com/congress-regis…

English

1.2K

ICTHIC retweetet

ICTHIC Magazine@icthicmagazine·1 Mar

The Abstract submission deadline for the 12th International Conference on Thrombosis and Hemostasis issues in cancer is near! Send your scientific contributions by March 11, 2024. Check it out here: medicalhosting.org/ICTHIC/index.p… @ICTICH #thrombosis #cancer #hemostasis #12ICTHIC

English

405

ICTHIC@ICTHIC·10 Eki

@aakonc @ClionaKirwan @luistrombo

ICTHIC Magazine@icthicmagazine

What are the latest insights on the management of incidental VTE in cancer patients? @luistrombo will answer this question during our webinar: "Updates in Cancer-Associated Thrombosis" October 27, 2022, 18.00 CET Register here rb.gy/egwmtm #thrombosis #cancer

QAM

ICTHIC@ICTHIC·15 Haz

Thurs 16 June 1700 CET at eha22.ehaweb.org/eha/eha2022/en… . 📜 soon in @Hemasphere_EHA. Read now at ehaweb.org/assets/Uploads… .@AnnaFalanga19 @LeaderAvi

Anna Falanga@AnnaFalanga19

Happy to chair with @LeaderAvi and present with Chiara @EHA_Hematology GLs on antithrombotic Rx in thrombocytopenic cancer patients

English

ICTHIC retweetet

Anna Falanga@AnnaFalanga19·15 Haz

Happy to chair with @LeaderAvi and present with Chiara @EHA_Hematology GLs on antithrombotic Rx in thrombocytopenic cancer patients

Avi Leader@LeaderAvi

Excited to co-chair #EHA2022 session on @EHA_Hematology GLs on antithrombotic Rx in thrombocytopenic cancer pts, led by @AnnaFalanga19. Thurs 16 June 1700 CET at eha22.ehaweb.org/eha/eha2022/en… . 📜 soon in @Hemasphere_EHA. Read now at ehaweb.org/assets/Uploads… . @escardio @bagoly18

English

ICTHIC retweetet

Marc Carrier@MarcCarrier1·29 May

Fantastic meeting #icthic2022 with many Ottawa 🇨🇦 colleagues and previous, new and future Italian 🇮🇹 fellows training @OttawaHospital. Fostering new and exciting collaborations for the prevention and management of cancer-associated thrombosis. Arrivederci nel 2024

Bergamo, Lombardy 🇮🇹 English

ICTHIC retweetet

Alok Khorana, MD@aakonc·29 May

Stars of @ICTHIC #icthic2022 with our founding Chair Prof Falanga. The future of CAT is 🔥🔥🔥

English

ICTHIC retweetet

Cihan Ay@Cihan_Ay_MD·27 May

What an emotion to be back again to a face-to-face conference with so many colleagues and friends from the thrombosis-haemostasis-cancer community for the 11th ICTHIC in Bergamo. #icthic2022 #icthic22

Bergamo, Lombardy 🇮🇹 English

ICTHIC retweetet

Alok Khorana, MD@aakonc·27 May

Dr @KSanfilippoMD presenting risk assessment of heme malignancies @ICTHIC

English

Entdecken

@MarcCarrier1 @jzbos @isth @SimonNoble @MarcelloDiNisio @aakonc @KSanfilippoMD @debsiegal